Enriched clinical annotations |
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched. |
Clinical annotation |
Category |
P-value |
Hits |
Hits(%) |
Module hits in category |
Arrays in annotation |
Arrays |
Prostate (Prostate cancer*) |
Prostate cancer* |
2.8e-32 |
40 |
47.6 |
84 |
101 |
1945 |
Hematologic cancer and cell line (Stimulated immune*) |
Stimulated immune* |
1.9e-15 |
16 |
36.3 |
44 |
53 |
1945 |
Hematologic samples and cell lines (Stimulated immune*) |
Stimulated immune* |
1.9e-15 |
16 |
36.3 |
44 |
53 |
1945 |
Macrophages (Stimulated immune*) |
Stimulated immune* |
1.9e-15 |
16 |
36.3 |
44 |
53 |
1945 |
Monocytes (Stimulated immune*) |
Stimulated immune* |
1.9e-15 |
16 |
36.3 |
44 |
53 |
1945 |
Hematologic cancer and cell line (Stimulated immune*) |
Stimulated immune* |
1.6e-08 |
14 |
16.6 |
84 |
53 |
1945 |
Hematologic samples and cell lines (Stimulated immune*) |
Stimulated immune* |
1.6e-08 |
14 |
16.6 |
84 |
53 |
1945 |
Macrophages (Stimulated immune*) |
Stimulated immune* |
1.6e-08 |
14 |
16.6 |
84 |
53 |
1945 |
Monocytes (Stimulated immune*) |
Stimulated immune* |
1.6e-08 |
14 |
16.6 |
84 |
53 |
1945 |
Lung carcinoid (Lung cancer) |
Lung cancer |
0.0002 |
4 |
66.6 |
6 |
20 |
276 |
Enriched GO annotations |
For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column). |
GO annotation |
P-value |
Hits |
Hits(%) |
Module genes |
Genes in annotation |
Genes |
phosphate metabolism |
1.4e-81 |
52 |
100 |
52 |
153 |
4566 |
phosphorus metabolism |
5.1e-81 |
51 |
98.0 |
52 |
138 |
4566 |
phosphorylation |
1.6e-74 |
51 |
98.0 |
52 |
176 |
4566 |
monovalent inorganic cation transporter activity |
6.8e-32 |
25 |
48.0 |
52 |
80 |
4566 |
transcription from Pol II promoter |
5.3e-26 |
25 |
48.0 |
52 |
130 |
4566 |
sodium ion transporter activity |
6.9e-26 |
19 |
36.5 |
52 |
50 |
4566 |
ion transporter activity |
8.2e-25 |
25 |
48.0 |
52 |
144 |
4566 |
metal ion transporter activity |
4.3e-24 |
19 |
36.5 |
52 |
60 |
4566 |
oxidative phosphorylation |
2.4e-23 |
13 |
25 |
52 |
17 |
4566 |
protein-disulfide reduction |
2.1e-21 |
12 |
23.0 |
52 |
16 |
4566 |
nucleoside monophosphate phosphorylation |
2.1e-20 |
12 |
23.0 |
52 |
18 |
4566 |
ATP synthesis coupled electron transport (sensu Eukarya) |
1.7e-19 |
11 |
21.1 |
52 |
15 |
4566 |
hydrogen ion transporter activity |
1.3e-18 |
15 |
28.8 |
52 |
50 |
4566 |
mitochondrial electron transport\, NADH to ubiquinone |
1.4e-17 |
10 |
19.2 |
52 |
14 |
4566 |
proton transport |
8.4e-16 |
12 |
23.0 |
52 |
35 |
4566 |
mitochondrion |
1.9e-14 |
20 |
38.4 |
52 |
207 |
4566 |
NADH dehydrogenase activity |
4.2e-14 |
10 |
19.2 |
52 |
25 |
4566 |
NADH dehydrogenase (ubiquinone) activity |
6.8e-14 |
10 |
19.2 |
52 |
26 |
4566 |
nucleotide metabolism |
2.6e-12 |
12 |
23.0 |
52 |
64 |
4566 |
monovalent inorganic cation transport |
3.6e-11 |
12 |
23.0 |
52 |
79 |
4566 |
mitochondrial inner membrane |
4.1e-10 |
9 |
17.3 |
52 |
41 |
4566 |
inner membrane |
5.7e-10 |
8 |
15.3 |
52 |
29 |
4566 |
cation transport |
5.3e-09 |
12 |
23.0 |
52 |
120 |
4566 |
mitochondrial membrane |
5.6e-09 |
9 |
17.3 |
52 |
54 |
4566 |
transcription factor activity |
1.3e-08 |
18 |
34.6 |
52 |
340 |
4566 |
proton-transporting ATP synthase complex (sensu Eukarya) |
3.8e-08 |
5 |
9.6 |
52 |
10 |
4566 |
vacuolar hydrogen-transporting ATPase |
3.8e-08 |
5 |
9.6 |
52 |
10 |
4566 |
electron transport |
1.2e-07 |
11 |
21.1 |
52 |
128 |
4566 |
oxidoreductase activity |
5.0e-07 |
14 |
26.9 |
52 |
254 |
4566 |
transcription regulator activity |
5.9e-07 |
23 |
44.2 |
52 |
703 |
4566 |
ion transport |
8.1e-07 |
12 |
23.0 |
52 |
188 |
4566 |
electron transporter activity |
1.0e-06 |
14 |
26.9 |
52 |
269 |
4566 |
DNA-directed RNA polymerase I activity |
2.9e-06 |
4 |
7.6 |
52 |
10 |
4566 |
DNA-directed RNA polymerase II activity |
2.9e-06 |
4 |
7.6 |
52 |
10 |
4566 |
DNA-directed RNA polymerase II\, core complex |
4.6e-06 |
4 |
7.6 |
52 |
11 |
4566 |
DNA-directed RNA polymerase III activity |
4.6e-06 |
4 |
7.6 |
52 |
11 |
4566 |
DNA-directed RNA polymerase activity |
6.9e-06 |
4 |
7.6 |
52 |
12 |
4566 |
cation transporter activity |
9.4e-06 |
6 |
11.5 |
52 |
45 |
4566 |
DNA-directed RNA polymerase II\, holoenzyme |
9.9e-06 |
4 |
7.6 |
52 |
13 |
4566 |
ammonia oxidation |
1.3e-05 |
3 |
5.7 |
52 |
5 |
4566 |
ubiquinol-cytochrome c reductase activity |
1.3e-05 |
3 |
5.7 |
52 |
5 |
4566 |
hydrogen-exporting ATPase activity\, phosphorylative mechanism |
2.7e-05 |
3 |
5.7 |
52 |
6 |
4566 |
regulation of transcription\, DNA-dependent |
5.2e-05 |
18 |
34.6 |
52 |
595 |
4566 |
mitochondrial electron transport chain |
0.0001 |
3 |
5.7 |
52 |
9 |
4566 |